Russia to administer personalized mRNA anti-tumor vaccine to 20 patients by end-2026

Russia's N. scientific director announced that 20 patients will receive a personalized anti-tumor mRNA vaccine by end-2026. The claim is an official statement with limited independent verification; it signals progress in Russia's oncology vaccine program but details on efficacy and trial design remain unclear.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works